Biotechnology (21) | Debenture Agreements (21)
Browse by Company
Recent Contracts
-
Form of Debenture
(Q BioMed Inc., Filed With SEC on February 16, 2021)
-
Form of Senior Convertible Debenture
(Inspyr Therapeutics, Inc., Filed With SEC on January 12, 2021)
-
Form of Debenture
(Q BioMed Inc., Filed With SEC on December 29, 2020)
-
Form of Senior Convertible Debenture
(Inspyr Therapeutics, Inc., Filed With SEC on October 29, 2020)
-
7% Original Issue Discount Senior Convertible Debenture due August 3, 2021
(VACCINEX, INC., Filed With SEC on August 14, 2020)
-
Form of 7% Original Issue Discount Senior Secured Convertible Debenture due August 3, 2021
(VACCINEX, INC., Filed With SEC on July 31, 2020)
-
Form of 5% Original Issue Discount Senior Secured Convertible Debenture dated June 26, 2020
(GeoVax Labs, Inc., Filed With SEC on June 26, 2020)
-
8% Convertible Debenture of Bioxytran, Inc. to Power Up Lending Group LLC in the Principal Amount of $64,900 dated March 18, 2020
(BIOXYTRAN, INC, Filed With SEC on March 26, 2020)
-
Form of Senior Convertible Debenture
(Inspyr Therapeutics, Inc., Filed With SEC on March 6, 2020)
-
8% Convertible Debenture of Bioxytran, Inc. to Power Up Lending Group LLC in the Principal Amount of $56,600 dated January 18, 2020
(BIOXYTRAN, INC, Filed With SEC on February 26, 2020)
